Related Experiment Video

Updated: Jun 24, 2026

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging
09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Mitochondrial serine protease HtrA2/Omi as a potential therapeutic target

Md Shenuarin Bhuiyan1, Kohji Fukunaga

  • 1Department of Pharmacology, Tohoku University, Japan.

Current Drug Targets
|April 10, 2009
PubMed

Insights

Dysregulated apoptosis contributes to diseases. Targeting the mitochondrial protease High temperature requirement A2 (HtrA2) offers a novel therapeutic strategy for various pathological conditions by modulating its role in apoptosis and mitochondrial quality control.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Deregulation of apoptosis is implicated in diseases like cancer, ischemia/reperfusion injury, and neurodegenerative disorders.
  • The mitochondrial serine protease High temperature requirement A2 (HtrA2)/Omi plays a critical role in various pathological conditions.
  • Recent studies highlight HtrA2's importance in mitochondrial quality control and apoptosis.

Purpose of the Study:

  • To critically discuss the rationale for therapeutically targeting HtrA2 signaling in pathological conditions.
  • To explore the molecular mechanisms underlying HtrA2 inhibition as a novel therapeutic strategy.
  • To review HtrA2's molecular origins, modulation, and potential as a drug target.

Main Methods:

  • Literature review of biochemical, structural, and genetic studies.
  • Critical discussion of HtrA2's role in disease pathogenesis.
  • Exploration of therapeutic strategies targeting HtrA2 signaling.

Main Results:

  • HtrA2 is a pivotal enzyme in apoptosis and mitochondrial homeostasis.
  • Modulation of HtrA2 activity presents a promising therapeutic avenue.
  • Understanding HtrA2's mechanisms is key to developing new treatments.

Conclusions:

  • Therapeutic targeting of HtrA2 signaling holds significant potential for treating diseases linked to apoptosis deregulation.
  • HtrA2 inhibition represents a novel strategy with broad therapeutic perspectives.
  • Further research into HtrA2's functions and modulation is warranted for drug development.

More Related Videos

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis11:51

Preparation of Mitochondria from Ovarian Cancer Tissues and Control Ovarian Tissues for Quantitative Proteomics Analysis

Published on: November 18, 2019

Related Concept Videos

Translocation of Proteins into the Mitochondria01:19

Translocation of Proteins into the Mitochondria

Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
Mitochondrial Precursor Proteins01:39

Mitochondrial Precursor Proteins

Mitochondrial precursors are partially unfolded or loosely folded polypeptide chains. Newly synthesized precursors are inhibited from spontaneously folding into their native conformation by the cytosolic chaperones, heat shock proteins 70 (Hsp70), and mitochondrial import stimulation factors (MSFs). Precursors bound to MSFs are guided to the TOM70-TOM37 receptors, while precursors bound to Hsp70  chaperones are targetted to TOM20-TOM22 receptor complexes.
Most of the mitochondrial precursors...
Energy to Drive Translocation01:37

Energy to Drive Translocation

Mitochondrial protein import is powered by two distinct energy sources: ATP hydrolysis and electrochemical potential across the inner membrane. Newly synthesized precursors are bound by cytosolic chaperones of the Hsp70 family, which guide them to the import receptors on the mitochondrial surface. Utilizing the energy of ATP hydrolysis, Hsp70 chaperones transfer these precursors to the TOM receptors on the mitochondrial outer membrane.
Generally, polypeptides are unfolded by two distinct...
Mitochondrial Protein Sorting01:39

Mitochondrial Protein Sorting

Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death.  Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
ATP Synthase: Mechanism01:48

ATP Synthase: Mechanism

In animals, the mitochondrial F1F0 ATP synthase is the key protein that synthesizes ATP molecules through a complex catalytic mechanism. While the nuclear genome encodes the majority of ATP synthase subunits, the mitochondrial genome encodes some of the enzyme's most critical components. The formation of this multi-subunit enzyme is a complex multi-step process regulated at the level of transcription, translation, and assembly. Defects in one or more of these steps can result in decreased ATP...